Take Control of Your Health

The DEX-G2 Biomarker Blood Test for Early Detection of Gastric Cancer Is Coming Soon to U.S. Healthcare Providers

Learn more About the Test

A Better Way to Catch Gastric Cancer Early.

Gastric cancer, also called stomach cancer, is the third leading cause of cancer deaths worldwide mainly because it’s often found too late.

Most people don’t feel symptoms early.
Gastric cancer is often silent until it spreads—when survival drops to just 30%. 1

Current tests are invasive.
Endoscopy is costly and hard to access—especially in underserved communities.

Early detection could save your life.
When found early, survival rates rise to 70–90%. 1

You don’t have to wait for symptoms.
The DEX-G2 blood test can help detect gastric cancer early when it’s most treatable.

The DEX-G2 Gastric Cancer Test

What is the DEX-G2 Test?

DEX-G2 is a simple, stress-free blood test that helps detect gastric (stomach) cancer at its earliest—and most treatable—stage.

It offers a minimally invasive alternative to traditional procedures like endoscopy, with no scopes, sedation, or hospital visits required. Just a quick blood draw from your healthcare provider.

Clinically validated - With 95% sensitivity for early-stage detection

Affordable and accessible - Available through any licensed healthcare provider

Finds early-stage disease - More treatment options are available with a better chance at recovery

Confidence and peace of mind - Allows you to be proactive about your health.

Catching gastric cancer early means more treatment options, less uncertainty, and a better chance at recovery.

SOLUTION

What makes DEX-G2 Different?

DEX-G2 is a new kind of blood test that helps find stomach cancer early—before symptoms even show up. It’s fast, easy, and doesn’t involve scopes or sedation. Just a small blood draw from your doctor.

How It Works


DEX-G2 uses a special dual-technology system that looks for miRNAs—tiny signals in your blood that can be linked to cancer.

Cell-Free miRNAs

Float freely in the blood and show changes happening in your body.

+

Exosomal miRNAs

Come directly from cancer cells, giving a more tumor-specific signal.

This two-step approach makes DEX-G2 more accurate, helping doctors catch stomach cancer earlier, when treatment works best.

Who Should Consider the DEX-G2 Test?

While anyone concerned about their risk should talk with their doctor, this test may be especially helpful for people who have one or more risk factors1 for gastric cancer, including:

Family & Medical History

  • You’re over 50

  • You have a family history of stomach cancer

  • You’ve had an H. Pylori infection

Lifestyle Factors

  • You smoke

  • You drink heavily

  • You eat a lot of smoked, salted, or pickled foods

Where you Live or your Background

  • You’re of Asian, Hispanic/Latino, or Eastern European descent

  • You live in an area with higher rates of stomach cancer (like South Texas)

If you have concerns or symptoms like persistent indigestion, stomach pain, or unexplained weight loss, speak with your doctor about whether the DEX-G2 test is right for you. 

What Should I Do Next?

Take the First Step Toward Early Detection

If you or a loved one is at risk for gastric cancer, talk to your doctor about early detection options. When available, the DEX-G2 blood test offers a simple, stress-free way to get answers—before symptoms begin and when treatment is more effective.

Because early detection is your best, life-saving defense against gastric cancer.

Coming Soon to U.S. Healthcare Providers

  • Advances in screening and detection of gastric cancer - PMC

    https://pmc.ncbi.nlm.nih.gov/articles/PMC9322671/

The DEX-G2 biomarker blood test will soon be available through licensed healthcare providers across the United States. Please check this page often for updates on how and where to get tested.

References: